Patents-Review.com
🔗 Permalink
Assignee profile:

Step Pharma S.A.S.

City:

Paris

Country:

France

Published Applications:

10

Last publication date:

2025-02-27

Patent Grants:

7

Last grant date:

2025-07-29

Top Inventors for applications by Step Pharma S.A.S.

These are the the leading inventors for applications assigned to Step Pharma S.A.S.:

  • Lorna Duffy 5 Nottingham, Nottinghamshire, United Kingdom
  • Abdul Quddus 5 Nottingham, Nottinghamshire, United Kingdom
  • Louise Birch 5 Nottingham, Nottinghamshire, United Kingdom
  • Saleh Ahmed 5 Nottingham, Nottinghamshire, United Kingdom

Recent patent applications by Step Pharma S.A.S.

Step Pharma S.A.S. based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-02-27 ✅ Patent 12,371,419 granted on 2025-07-29
US20250066324A1
Chemistry; metallurgy

AMINOPYRIMIDINE/PYRAZINE DERIVATIVES AS CTPS1 INHIBITORS

 #2 | 2024-01-11 ✅ Patent 12,503,466 granted on 2025-12-23
US20240010645A1
Chemistry; metallurgy

Aminothiazole Compounds as Inhibitors of CTPS1

 #3 | 2023-06-15 ✅ Patent 12,319,680 granted on 2025-06-03
US20230183229A1
Chemistry; metallurgy

Compounds

 #4 | 2023-03-23
US20230086703A1
Chemistry; metallurgy

N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases

 #5 | 2023-01-19
US20230020663A1
Chemistry; metallurgy

SULFONAMIDE INHIBITORS AS CTPS1 INHIBITORS

 #6 | 2023-01-05
US20230002352A1
Chemistry; metallurgy

SULFONAMIDE DERIVATIVES AS CTPS1 INHIBITORS

 #7 | 2022-10-13 ✅ Patent 12,466,810 granted on 2025-11-11
US20220324837A1
Chemistry; metallurgy

N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases

 #8 | 2021-12-16 ✅ Patent 11,987,573 granted on 2024-05-21
US20210387965A1
Chemistry; metallurgy

Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitors

 #9 | 2021-12-09 ✅ Patent 11,505,547 granted on 2022-11-22
US20210380575A1
Chemistry; metallurgy

Compounds

 #10 | 2021-01-07 ✅ Patent 11,655,246 granted on 2023-05-23
US20210002269A1
Chemistry; metallurgy

Aminothiazole compounds as inhibitors of CTPS1

Also check out STEP PHARMA S.A.S.'s (Paris, France) applicant profile with 8 patent applications submitted.

AssigneeID:

318382 ⎘